Macquarie Group’s 9 Meters Biopharma NMTR Stock Holding History

Macquarie Group’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-63	Closed	-$1K	–	1941
2019 Q2	$1K	Buy	+63	New	+$1.89K	﹤0.01%	1826

Other funds holding NMTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Macquarie Group's NMTR Position: Q3 2019 in Review

Macquarie Group sold out of 9 Meters Biopharma (NMTR) in Q3 2019, closing a stake of 63 shares — an estimated $1K sold.

Macquarie Group first reported a position in NMTR in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 19 funds tracked by Wall St. Rank hold NMTR as of Q3 2019.

Macquarie Group reported no remaining 9 Meters Biopharma position as of Q3 2019 after selling out during the quarter.
Macquarie Group sold 63 9 Meters Biopharma shares in Q3 2019, an estimated $1K.
Macquarie Group first reported a position in 9 Meters Biopharma in Q2 2019 and held it in 1 quarter.
Macquarie Group's 9 Meters Biopharma position peaked at $1K in Q2 2019.
19 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2019.

Based on Macquarie Group's 13F filing for Q3 2019, filed 14 Nov 2019.